09/28/2026
Bezisterim – the Best Long COVID Drug Trial Yet? BioVie Aims for a Big, Phase III Trial
The topline results for Bezesterim - a novel anti-neurinflammatory - drug - rolled in for long COVID.
Early results suggested that Bezesterim produced moderate results across a broad range of symptoms, making it the most successful long COVID trial yet.
Better yet may be coming when researchers roll in the extensive biomarker results.
Check it out
Bezisterim produces moderate and broad treatment effects in several different long COVID subsets. BioVie, the drug manufacturer, hopes to move forward with a big phase III trial.